查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2022-2029 年全球间歇性导管市场
市场调查报告书
商品编码
1140740

2022-2029 年全球间歇性导管市场

Global Intermittent Catheter Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 170 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

尿失禁的增加正在推动市场增长

无心漏尿称为尿失禁。它是由尿道括约肌的丧失或无力引起的。它可能与压力源一起发生，例如在怀孕期间和之后的咳嗽，并且在肥胖等情况下更为常见。根据美国泌尿外科协会的报告，美国四分之一到三分之一的男性和女性患有尿失禁。大约 3300 万人患有膀胱过度活动症 (OAB)，伴有或不伴有尿急、尿频和急迫性尿失禁。 OAB 是一种尿失禁，也称为“急迫性”尿失禁。 OAB 影响着美国 30% 以上的男性和 40% 的女性，并影响着人们的生活。国家医学图书馆报告说，女性比男性更常见尿失禁。美国有 24% 到 45% 的女性报告有一定程度的尿失禁。 7% 到 37% 的 20 到 39 岁的女性抱怨有一定程度的尿失禁。在美国，据说国际上约有 1300 万人受到尿失禁的影响。随着人年龄的增长，这种疾病变得更有可能发生。因此，老年人口的增加也将加速市场增长。

此外，对间歇性导尿管的需求增加将很快推动间歇性导尿管行业的增长，因为与其他商品相比，这些设备更易于操作且导尿成本更低。预计。此外，预计全球尿失禁患者数量的增加和老年人口的增加将推动预测期内的市场增长。

但是，与间歇性导管相关的风险阻碍了市场增长。频繁使用间歇性导尿管会带来潜在风险，例如尿路感染 (UTI)。其他风险包括尿道狭窄、尿道炎、尿道出血、膀胱结石和生殖器感染。与使用间歇性导管相关的并发症是预计在预测期内抑制全球市场增长的关键因素。

地理渗透率

北美地区有望主导全球间歇导管市场

该研究按地区分析了全球市场的间歇性导管市场，包括北美、欧洲、亚太地区、南美、中东和非洲。

到 2021 年，北美在全球间歇性导管市场中占有压倒性的份额。预计美国在预测期内将代表北美的大幅增长。该国医疗基础设施完善，人均医疗费用高，导致间歇性导管市场巨大。预计对研发和先进产品开发的大量投资将推动整个地区的市场增长。

由于人口众多，主要在印度和中国，预计亚太地区的间歇性导管市场将在预测期内快速增长。此外，预计医疗保健成本上升和各种泌尿系统疾病患病率激增将推动亚太地区间歇性导管市场的增长。

竞争格局

由于主要医疗公司的存在，间歇性导管市场是一个竞争激烈的市场。为全球市场增长做出贡献的一些领先的间歇性导管製造商包括： Braun Melsungen AG、ConvaTec Healthcare B S.a.r.l、Coloplast Ltd.、Cook Medical、Teleflex Incorporated、Medline Industries Inc、Medtronic、C.R. Bard Inc、Adapta Medical、Becton Dickson Company 等。主要参与者正在为间歇性导管市场的全球增长采用新型的启动和扩展策略。 2022年3月，全球医疗产品及科技公司康威达集团完成对Triad Life Sciences Inc.的收购。收购的重点是专注-创新-简化-构建-执行战略，以加强 Convatec 在美国的 AWC 地位（重点）和补充和创新技术平台，以增强先进的伤口管理和患者结果有助于确保获得（创新） 2022 年 6 月，全球领先的医疗技术提供商 Teleflex 在澳大利亚和新西兰推出了新的 Arrow 压力注射中线导管。该产品旨在增强中线产品组合，以满足临床医生不断扩大的需求并提高患者安全性。这种新的 20 厘米箭头压力可注射中线带有亮黄色的毂和标籤，可帮助临床医生剋服导管识别的困惑，这可能导致可能伤害患者的注射错误。它有 1 流明和 2 流明配置。 2022 年 2 月，全球领先的医疗技术公司 Teleflex 获得了 FDA 的扩大适应症批准，用于在穿越慢性全闭塞经皮冠状动脉介入治疗 (CTO PCI) 程序中使用专用导管和冠状动脉导丝。 2021 年 2 月，Teleflex, Inc. 完成了对领先止血器製造商 Z-Medica LLC 的收购。 Z-Medica 专注于创新出血控制产品的销售和营销。

COVID-19 的影响预测全球间歇性导管市场将稳定增长。

由于非 COVID-19 相关的医疗保健设施以正常速度运行，预计全球对间歇性导管的需求增长将在整个 COVID-19 流行期间保持稳定。在当前的 COVID-19 大流行之后，间歇性导管市场预计将保持稳定。市场进入者必须专注于解决 COVID-19 大流行带来的供应链挑战并设计适当的解决方案。

全球间歇性导管市场报告包括大约 61 个市场数据表、53 个图表和 170 页

内容

第 1 章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按类型划分的市场细分
  • 按指标划分的市场细分
  • 最终用户的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
    • 促进因素
      • 尿失禁增加
      • 不断增长的老年人口
    • 抑制因素
      • 与间歇性使用导管相关的风险
    • 影响分析

第 5 章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按类型

  • 无涂层
  • 涂层
  • 含润滑剂

第 8 章适应症

  • 尿失禁
  • 普通外科
  • 脊髓损伤
  • 其他

第 9 章最终用户

  • 医院
  • 医学研究所
  • 门诊手术中心

第 10 章按地区划分

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 11 章竞争格局

  • 竞争场景
  • 市场情况/份额分析
  • 併购分析

第 12 章公司简介

  • B.Braun Melsungen AG
    • 公司概况
    • 产品组合和内容
    • 主要亮点
    • 财务摘要
  • ConvaTec Healthcare B S.a.r.l.
  • Coloplast Ltd..
  • Cook Medical.
  • Teleflex Incorporated.
  • Medline Industries Inc.
  • Medtronic
  • C. R. Bard Inc.
  • Adapta Medical
  • Becton Dickson Company（*LIST NOT EXHAUSTIVE）

第 13 章重要注意事项

第 14 章 DataM

简介目录
Product Code: DMPH3139

Market Overview

Intermittent Catheter Market was valued at USD YY million in 2021. It is forecasted to reach USD YY million by 2029, growing at a CAGR of 4.1% during the forecast period (2022-2029).

An Intermittent Catheter is used in patients who are unable to do so normally to drain urine from the bladder. These catheters are meant to be used for a brief period. These are indicated for conditions like urinary leakage, incontinence, and other problems with the bladder. Neurogenic bladder diseases like spinal cord injury, multiple sclerosis, or spina bifida, as well as non-neurogenic bladder diseases, may cause urinary incontinence. The periodic catheter is placed into the urethra, and urine is gathered into the collection bag with the help of the catheter hose. A catheter should be removed after emptying the bladder. The growth of the global market for intermittent catheters is projected to rely on popularity due to a lower risk of CAUTI (catheter-acquired urinary tract infection) and the advent of more effective, less invasive, and newer catheters.

Market Dynamics: The rise in prevalence of urinary incontinence drives market growth

The unintentional leakage of urine is urinary incontinence. The urinary sphincter's power is either lost or diminished. It can arise due to stress factors such as coughing during and after gestation and is more frequent in conditions such as obesity. According to the American Urology Association report, a quarter to a third of men and women in the U.S. suffer from urinary incontinence. About 33 million have overactive bladder (OAB), representing symptoms of urgency, frequency and with or without urge incontinence. OAB is a type of urinary incontinence, also called "urgency" incontinence. OAB affects more than 30% of men and 40% of women in the U.S. It affects people's lives. According to the National library of medicine report, women's urinary incontinence is more frequent than men's. In America, 24% to 45% of women report some degree of urinary incontinence. 7% to 37% of women ages 20 to 39 report some degree of urinary incontinence. In addition, approximately 13 million people are internationally affected by urinary incontinence in America. The chances of the disease increase with the age of human beings. Thus, the increase in the older population also accelerates the market growth.

Also, the increased demand for intermittent urinary catheters is expected to fuel the growth of the intermittent catheter industry shortly because, relative to other goods, these instruments provide greater ease of handling and low catheterization costs. Furthermore, the rise in urinary incontinence cases and the increase in the geriatric population globally are anticipated to drive market growth during the forecast period.

However, risks associated with intermittent catheters hamper the market growth. The frequent use of intermittent catheters leads to potential risks such as urinary tract infections (UTI). Other risks include urethral stricture, urethritis, urethral bleeding, bladder stones and genital infection. The complications associated with the use of intermittent catheters are a key factor expected to curtail the growth of the global market over the forecast period.

Market Segmentation: The non-Coated segment is projected to be the dominant segment in the market during the forecast period.

Based on the type, the intermittent catheter market has been classified into non-coated, coated and pre-lubricated.

Non-Coated dominated the global market in 2021, owing to the wide usage of Non coated owing to the modern Indications used in the manufacturing of Non-Coated, which reduces allergies associated with latex indications, whereas coated is expected to present considerable growth in the near future. As a consequence of the adoption of intermittent antimicrobial catheters, that helps to mitigate infections induced by catheterization.

The global intermittent catheter market is segmented based on end-user, which includes hospitals and medical research centers and ambulatory surgery centers.

Hospitals held a significant market share in the global market during the forecast period as the majority of the urinary incontinence and urinary infection cases are brought directly into the hospitals for treatment, which supports the segment growth during the forecast period. Moreover, the Medical Research Centers is expected to project a considerable CAGR during the forecast period. Increasing research and product development investments are expected to propel the segment's growth in the near future.

Geographical Penetration: North America region is expected to dominate the global intermittent catheter market

Based on geography, the study analyzes the Intermittent Catheter market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

North America is dominant in the global intermittent catheter market in 2021. The U.S. is expected to represent considerable growth in North America during the forecast period. The country's well-established healthcare infrastructure and high healthcare expenditure per capita result in a huge market for Intermittent Catheters. Significant investment in R&D and advanced product development is expected to propel the market growth across the region.

The intermittent catheter market for the Asia Pacific is expected to observe rapid growth over the forecast period, backed by the large population base, especially in India and China. Moreover, the rise in health care expenditure and the rapidly increasing prevalence of various urologic diseases are expected to augment the growth of the Asia Pacific intermittent catheter market.

Competitive Landscape:

The intermittent catheter market is highly competitive, owing to the presence of big medical companies. The key Intermittent Catheter players contributing to the growth of the global market include. Braun Melsungen AG, ConvaTec Healthcare B S.a.r.l, Coloplast Ltd.., Cook Medical., Teleflex Incorporated., Medline Industries Inc., Medtronic, C. R. Bard Inc, Adapta Medical, Becton Dickson Company, among others. The major players are adopting new Type launch and expansion strategies for global growth in the Intermittent Catheter market. In March 2022, Convatec Group, global medical products and technologies company completed the acquisition of Triad Life Sciences Inc. This acquisition focused on the Focus-Innovate-Simplify-Build-Execute strategy and helped to strengthen Convatec's AWC position in the US (Focus) and to secure access to a complementary and innovative technology platform (Innovation) that enhances advanced wound management and patient outcomes. In June 2022, Teleflex, a leading global provider of medical technologies, launched a new Arrow Pressure Injectable Midline Catheter in Australia and New Zealand. It enhances the Midline portfolio to meet the expanded needs of clinicians and is designed to improve patient safety. This new 20 cm Arrow Pressure Injectable Midline with brightly colored yellow hubs and labeling help clinicians overcome catheter identification confusion, which can lead to infusion mistakes that can harm patients. It is available in 1-lumen and 2-lumen configurations. In February 2022, Teleflex, a leading global provider of medical technologies, received FDA approval for Expanded Indication for specialty catheter and coronary guidewire use in crossing chronic total occlusion percutaneous coronary interventions (CTO PCI) Procedures. In February 2021, Teleflex Inc. completed the acquisition of Z-Medica LLC, an industry-leading manufacturer of hemostatic products. Z-Medica focused on the sales and marketing of innovative hemorrhage control products.

COVID-19 Impact: Steady growth of the global intermittent catheter market.

The growth of the global demand for intermittent catheters is projected to stay stable throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for Intermittent Catheters is expected to stay stable in the wake of the current COVID-19 pandemic. Market participants must concentrate on solving the supply chain issues raised by the COVID-19 pandemic and designing appropriate solutions to resolve them.

The global intermittent catheter market report would provide an access to approximately 61 market data tables, 53 figures and 170 pages

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Type
  • 3.2. Market Snippet by Indication
  • 3.3. Market Snippet by End User
  • 3.4. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rise in Urinary Incontinence
      • 4.1.1.2. Increasing geriatric Population
    • 4.1.2. Restraints:
      • 4.1.2.1. Risks associated with the use of intermittent catheters
    • 4.1.3. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Type

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type Segment
  • 7.3. Market Attractiveness Index, By Type Segment
    • 7.3.1. Non-Coated*
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Coated
    • 7.3.3. Pre-Lubricated

8. By Indication

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication Segment
  • 8.3. Market Attractiveness Index, By Indication Segment
    • 8.3.1. Urinary Incontinence*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. General Surgery
    • 8.3.3. Spinal Injuries
    • 8.3.4. Others

9. By End User

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
  • 9.3. Market Attractiveness Index, By End User Segment
    • 9.3.1. Hospitals*
      • 9.3.1.1. Introduction
      • 9.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 9.3.2. Medical research centers
    • 9.3.3. Ambulatory Surgery Centers

10. By Region

  • 10.1. Introduction
  • 10.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 10.3. Market Attractiveness Index, By Region
  • 10.4. North America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. U.S.
      • 10.4.6.2. Canada
      • 10.4.6.3. Mexico
  • 10.5. Europe
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. Germany
      • 10.5.6.2. U.K.
      • 10.5.6.3. France
      • 10.5.6.4. Italy
      • 10.5.6.5. Spain
      • 10.5.6.6. Rest of Europe
  • 10.6. South America
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.6.6.1. Brazil
      • 10.6.6.2. Argentina
      • 10.6.6.3. Rest of South America
  • 10.7. Asia Pacific
    • 10.7.1. Introduction
    • 10.7.2. Key Region-Specific Dynamics
    • 10.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.7.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.7.6.1. China
      • 10.7.6.2. India
      • 10.7.6.3. Japan
      • 10.7.6.4. Australia
      • 10.7.6.5. Rest of Asia Pacific
  • 10.8. Middle East and Africa
    • 10.8.1. Introduction
    • 10.8.2. Key Region-Specific Dynamics
    • 10.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
    • 10.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.8.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. B. Braun Melsungen AG*
    • 12.1.1. Company Overview
    • 12.1.2. Type Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. ConvaTec Healthcare B S.a.r.l.
  • 12.3. Coloplast Ltd..
  • 12.4. Cook Medical.
  • 12.5. Teleflex Incorporated.
  • 12.6. Medline Industries Inc.
  • 12.7. Medtronic
  • 12.8. C. R. Bard Inc.
  • 12.9. Adapta Medical
  • 12.10. Becton Dickson Company(*LIST NOT EXHAUSTIVE)

13. Premium Insights

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us